Skip to main content
PMC home page
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 1980 Aug;18(2):338–345. doi: 10.1128/aac.18.2.338

Comparison of in vitro activity of Sch 21420, a gentamicin B derivative, with those of amikacin, gentamicin, netilmicin, sisomicin, and tobramycin.

C Thornsberry, A L Barry, R N Jones, C N Baker, R E Badal, R R Packer
PMCID: PMC283992  PMID: 7447410

Abstract

Sch 21420 is a new aminoglycoside synthesized from gentamicin B. Susceptibility tests with Sch 21420, amikacin, gentamicin, netilmicin, sisomicin, and tobramycin were performed on a variety of bacterial species including 44 with known mechanisms of resistance to aminoglycosides. Sch 21420 and amikacin had similar effects on all except Haemophilus influenzae and Neisseria species, which were more susceptible to amikacin. Except with some strains of Serratia marcescens, the drugs used were bactericidal. Sch 21420 and amikacin were more stable than the other four aminoglycosides in the presence of the inactivating enzymes produced by some strains. Strains which were very resistant to Sch 21420 and emikacin either were permeability mutants or produced AAC (6')-I inactivating enzyme. The effect of cations on the susceptibilities of these strains to Sch 21420 and amikacin was seen mostly with Pseudomonas aeruginosa and to Sch 21420 with Acinetobacter. Cations did not affect the susceptibilities of other Pseudomonas species, Enterobacteriaceae, Staphylococcus aureus, or Streptococcus faecalis to Sch 21420 or amikacin.

Full text

PDF
341

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Barry A. L., Thornsberry C., Jones R. N., Fuchs P. C., Gavan T. L., Gerlach E. H. Cefuroxime, an in vitro Comparison with Six Other Cephalosporins. Proc R Soc Med. 1977;70(Suppl 9):63–71. [PMC free article] [PubMed] [Google Scholar]
  2. Courvalin P., Davies J. Plasmid-medicated aminoglycoside phosphotransferase of broad substrate range that phosphorylates amikacin. Antimicrob Agents Chemother. 1977 Apr;11(4):619–624. doi: 10.1128/aac.11.4.619. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. D'amato R. F., Thornsberry C., Baker C. N., Kirven L. A. Effect of calcium and magnesium ions on the susceptibility of Pseudomonas species to tetracycline, gentamicin polymyxin B, and carbenicillin. Antimicrob Agents Chemother. 1975 May;7(5):596–600. doi: 10.1128/aac.7.5.596. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Davies J., Courvalin P. Mechanisms of resistance to aminoglycosides. Am J Med. 1977 Jun;62(6):868–872. doi: 10.1016/0002-9343(77)90654-4. [DOI] [PubMed] [Google Scholar]
  5. Jones R. N., Thornsberry C., Barry A. L., Fuchs P. C., Gavin T. L., Gerlach E. H. BL-S786, a new parenteral cephalosporin. II. In vitro antimicrobial activity comparison with six related cephalosporins. J Antibiot (Tokyo) 1977 Jul;30(7):583–592. doi: 10.7164/antibiotics.30.583. [DOI] [PubMed] [Google Scholar]
  6. Kabins S. A., Nathan C. In vitro activity of Sch 21420, derivative of gentamicin B, compared to that of amikacin. Antimicrob Agents Chemother. 1978 Nov;14(5):786–787. doi: 10.1128/aac.14.5.786. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Le Goffic F., Martel A., Capmau M. L., Baca B., Goebel P., Chardon H., Soussy C. J., Duval J., Bouanchaud D. H. New plasmid-mediated nucleotidylation of aminoglycoside antibiotics in Staphlococcus aureus. Antimicrob Agents Chemother. 1976 Aug;10(2):258–264. doi: 10.1128/aac.10.2.258. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Miller G. H., Chiu P. J., Waitz J. A. Biological activity of SCH 21420, the 1-N-S-alpha-hydroxy-beta-aminopropionyl derivative of gentamicin B. J Antibiot (Tokyo) 1978 Jul;31(7):688–696. doi: 10.7164/antibiotics.31.688. [DOI] [PubMed] [Google Scholar]
  9. Nagabhushan T. L., Cooper A. B., Tsai H., Daniels P. J., Miller G. H. The syntheses and biological properties of 1-N-(S-4-amino-2-hydroxybutyryl)-gentamicin B and 1-N-(S-3-amino-2-hydroxypropionyl)-gentamicin B. J Antibiot (Tokyo) 1978 Jul;31(7):681–687. doi: 10.7164/antibiotics.31.681. [DOI] [PubMed] [Google Scholar]
  10. Neu H. C., Fu K. P. 1-N HAPA gentamicin B, a new aminoglycoside active against gentamicin resistant isolates--activity compared to other aminoglycosides. J Antibiot (Tokyo) 1978 May;31(5):385–393. doi: 10.7164/antibiotics.31.385. [DOI] [PubMed] [Google Scholar]
  11. Sanders C. C., Sanders W. E., Jr, Goering R. V. In vitro studies with Sch 21420 and Sch 22591: activity in comparison with six other aminoglycosides and synergy with penicillin against enterococci. Antimicrob Agents Chemother. 1978 Aug;14(2):178–184. doi: 10.1128/aac.14.2.178. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Yu P. K., Washington J. A., 2nd In vitro evaluation of a semisynthetic derivative of gentamicin B (Sch 21420). Antimicrob Agents Chemother. 1978 May;13(5):891–892. doi: 10.1128/aac.13.5.891. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES